1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57817
Full metadata record
DC FieldValueLanguage
dc.creatorThales Pardini Fagundespt_BR
dc.creatorRonniel Morais Albuquerquept_BR
dc.creatorDiego Lopes Paim Mirandapt_BR
dc.creatorLuciana Castro Garcia Landeiropt_BR
dc.creatorGabriel Souza Fontes Ayrespt_BR
dc.creatorCaenna Corrêa e Correiapt_BR
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.date.accessioned2023-08-14T21:21:00Z-
dc.date.available2023-08-14T21:21:00Z-
dc.date.issued2021-
dc.citation.volume67pt_BR
dc.citation.issue1pt_BR
dc.citation.spage86pt_BR
dc.citation.epage90pt_BR
dc.identifier.doi10.1590/1806-9282.67pt_BR
dc.identifier.issn18069282pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57817-
dc.description.resumoOBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofRevista da Associação Médica Brasileira-
dc.rightsAcesso Abertopt_BR
dc.subjectEarly detection of cancerpt_BR
dc.subjectPandemicspt_BR
dc.subjectCoronavirus Infectionspt_BR
dc.subjectNeoplasmspt_BR
dc.subject.otherDetecção Precoce de Câncerpt_BR
dc.subject.otherPandemiaspt_BR
dc.subject.otherInfecções por Coronaviruspt_BR
dc.titleDealing with cancer screening in the covid-19 erapt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttp://https://www.scielo.br/j/ramb/a/5cXbV6J5xSB6mnPCs68X4nz/?lang=endoi:10.1590/1806-9282.67pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Dealing with cancer screening in the COVID-19 era pdfa.pdf217 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.